logo
Select company
Select metric
1.98Current Ratio
VS
Market
53
Sector
32
Industry
22
History
55
$ 2.93Close
$ 1.33 - $ 4.01 52-Week Range
Ticker Information

Ticker

AKBA

Company Name

AKEBIA THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

AKEBIA THERAPEUTICS INC - Current Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

AKBA - Current Ratio Historical data
DateCurrent AssetsCurrent RatioCurrent Liabilities
6/30/2025$ 234.66M1.98$ 118.72M
3/31/2025$ 203.78M2.23$ 91.23M
12/31/2024$ 113.83M1.41$ 80.91M
9/30/2024$ 100.12M1.52$ 65.71M
6/30/2024$ 112.1M1.04$ 107.3M
3/31/2024$ 112.94M1.7$ 66.49M
12/31/2023$ 118.15M1.18$ 99.87M
9/30/2023$ 109.6M1.38$ 79.7M
6/30/2023$ 118.45M1.28$ 92.18M
3/31/2023$ 120.72M1.46$ 82.94M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • AKEBIA THERAPEUTICS INC's latest trailing twelve months (TTM) Current Ratio stands at 2.15.
  • Over the past 5 years, AKEBIA THERAPEUTICS INC's average Current Ratio has been 1.57.
  • The median Current Ratio for AKEBIA THERAPEUTICS INC during this period was 1.47
  • AKEBIA THERAPEUTICS INC reached its highest Current Ratio over the past 5 years at 2.23.
  • The lowest Current Ratio recorded by AKEBIA THERAPEUTICS INC in the same timeframe 1.04

AKEBIA THERAPEUTICS INC's Current Ratio vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Current Ratio Benchmarks
CompanyCurrent Ratio
STOK : STOKE THERAPEUTICS INC 6.98DNA : GINKGO BIOWORKS HOLDINGS INC 5.41DAWN : DAY ONE BIOPHARMACEUTICALS INC 9.65GERN : GERON CORP 7.87IOVA : IOVANCE BIOTHERAPEUTICS INC 3.27MRVI : MARAVAI LIFESCIENCES HOLDINGS INC 5.16KROS : KEROS THERAPEUTICS INC 21.11CRMD : CORMEDIX INC 7.82NAGE : NIAGEN BIOSCIENCE INC 3.88ZYME : ZYMEWORKS INC 7.69

Definition of Current Ratio

[Calculation] The current ratio is a liquidity indicator that describes the company’s ability to pay short-term obligations due within one year. Calculated by dividing current assets [AssetsC] by current liabilities [LiabilitiesC].
AssetsC / LiabilitesC
(=) Current Ratio
Current Ratio for AKEBIA THERAPEUTICS INC is calculated as follows: AssetsC [ $ 391M ] / LiabilitesC [ $ 181.46M ]
(=) Current Ratio [ 2.15 ]

AKBA - Current Ratio, Last 5 years

1.04

Minimum

Jun 30, 2024

2.23

Maximum

Mar 31, 2025

1.57

Average

1.47

Median

Current Ratio Benchmark Analysis

The chart above depicts the distribution of Current Ratio for companies in the Total Stock Market. The average Current Ratio of the companies is 2.02 with a standard deviation of 1.44.
The following table provides additional summary stats:
Current Ratio in the Market:
filtered constituents3.2K
min0
max6.79
average2.02
median1.62
std1.44